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dLetter to the Editor
uthor’s reply
ear Dr Bauters,
Thank you for your comments on our study. As you men-
ioned, brain natriuretic peptide (BNP) and white blood cell
WBC) count were both independent predictors of left ven-
ricular (LV) remodeling after myocardial infarction (MI), but
BC count was not an independent predictor when BNP was
aken into account in your study.
Peak peripheral blood mononuclear cell (PBMC) count,
.e. monocyte count plus lymphocyte count, was superior
or predicting LV remodeling to WBC count in our study.
herefore, it would be interesting to determine whether
BMC count is an independent predictor of LV remodeling
fter MI. Unfortunately, BNP data on admission or prior to
ischarge have not been collected from all of the patients.
Further studies are necessary to elucidate the usefulness
f peak PBMC count to predict LV remodeling after MI.
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